Rapid site-directed mutagenesis on full-length plasmid DNA by using designed restriction enzyme assisted mutagenesis.
- Author:
Baozhong ZHANG
1
;
Duoliang RAN
;
Xin ZHANG
;
Xiaoping AN
;
Yunzhu SHAN
;
Yusen ZHOU
;
Yigang TONG
Author Information
1. State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Science, Beijing 100071, China.
- Publication Type:Journal Article
- MeSH:
Amino Acid Sequence;
Base Sequence;
DNA;
genetics;
DNA Restriction Enzymes;
genetics;
DNA-Directed DNA Polymerase;
genetics;
Molecular Sequence Data;
Mutagenesis, Site-Directed;
methods;
Plasmids;
Receptors, Polymeric Immunoglobulin;
genetics
- From:
Chinese Journal of Biotechnology
2009;25(2):306-312
- CountryChina
- Language:Chinese
-
Abstract:
To use the designed restriction enzyme assisted mutagenesis technique to perform rapid site-directed mutagenesis on double-stranded plasmid DNA. The target amino acid sequence was reversely translated into DNA sequences with degenerate codons, resulting in large amount of silently mutated sequences containing various restriction endonucleases (REs). Certain mutated sequence with an appropriate RE was selected as the target DNA sequence for designing mutation primers. The full-length plasmid DNA was amplified with high-fidelity Phusion DNA polymerase and the amplified product was 5' phosphorylated by T4 polynucleotide kinase and then self-ligated. After transformation into an E. coli host the transformants were rapidly screened by cutting with the designed RE. With this strategy we successfully performed the site-directed mutagenesis on an 8 kb plasmid pcDNA3.1-pIgR and recovered the wild-type amino acid sequence of human polymeric immunoglobulin receptor (pIgR). A novel site-directed mutagenesis strategy based on DREAM was developed which exploited RE as a rapid screening measure. The highly efficient, high-fidelity Phusion DNA polymerase was applied to ensure the efficient and faithful amplification of the full-length sequence of a plasmid of up to 8 kb. This rapid mutagenesis strategy avoids using any commercial site-directed mutagenesis kits, special host strains or isotopes.
